Most Common Signs of Prostate Cancer
Prostate cancer is the second most common type of cancer diagnosed in men. According to the American Cancer Society, about
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
Prostate cancer is the second most common type of cancer diagnosed in men. According to the American Cancer Society, about
When you’re diagnosed with prostate cancer, life can start changing very rapidly. There will be new physical and emotional burdens
When someone is first diagnosed with cancer, there’s a lot to take in and process. Oncologist Dr. Seth Berk, who
Most people associate lung cancer with smoking. While tobacco is the leading cause of lung cancer, it’s not the only
For many years, there were only three ways to treat cancer: chemotherapy, surgery and radiation. But recently, a new form
It’s estimated that more than half of people diagnosed with lung cancer lose their battle within the first year. This
Cancer treatment has come a long way. Today, there are more options – and more effective options – than ever
When someone is diagnosed with cancer, one of the first thoughts they have is: What could I have done differently
In 2018 alone, an estimated 234,030 people will be diagnosed with lung cancer in the U.S. Unfortunately, many of those
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.